Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Annual Reports & Annual General Meetings
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » Annual Report 30 June 2018
Annual Report 30 June 2018
November 8, 2018 •
Category
•
Author Name
Latest News
2019 Notice of Meeting and Proxy Form
October 29, 2019
BioDiem 2019 AGM Notice of Meeting and Proxy Form
Read More
2019 Annual Report
October 28, 2019
BioDiem Annual Report 2019
Read More
